Form 4: Myriad Genetics Executive Sells 2,100 Shares

Dale Muzzey, Chief Scientific Officer of Myriad Genetics, sold 2,100 shares of common stock on September 11, 2024, at a price of $26.172 per share.

Summary

• On September 11, 2024, Dale Muzzey, the Chief Scientific Officer of Myriad Genetics Inc., sold 2,100 shares of the company's common stock.
• The sale was executed at a price of $26.172 per share.
• Following the transaction, Muzzey directly owns 108,013 shares of Myriad Genetics Inc.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing detailing a stock sale by a company executive. It doesn't inherently convey positive or negative sentiment, but rather provides factual information about the transaction.

Industry Context

Form 4 filings are standard disclosures required by the SEC when company insiders, like officers and directors, trade their company's stock. These filings are closely watched by investors for insights into management's perspective on the company's valuation and future prospects.

Stakeholder Impact

• The sale of shares by a high-ranking officer could be perceived negatively by some shareholders, potentially leading to speculation about the officer's confidence in the company's future performance.

Key Dates